Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer — Stella

Recruiting

Back to Bladder Cancer trials

Trial locations(1 site)

China

The Second Hospital of Lanzhou University, Lanzhou, Gansu

Key details

Sponsor

Zhilong Dong

Enrollment target

~400 participants

Started

February 2026

Primary completion

July 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov